Related references
Note: Only part of the references are listed.Molecular markers in bladder cancer
Francesco Soria et al.
WORLD JOURNAL OF UROLOGY (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2019)
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer
David D'Andrea et al.
BJU INTERNATIONAL (2019)
Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
Makito Miyake et al.
THERANOSTICS (2019)
Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature
Andrea Mari et al.
WORLD JOURNAL OF UROLOGY (2018)
The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
Mustafa Yassin Taher et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature
Luis A. Kluth et al.
EUROPEAN UROLOGY (2015)
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guerin: Results of a Retrospective Multicenter Study of 2451 Patients
Paolo Gontero et al.
EUROPEAN UROLOGY (2015)
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
Atiqullah Aziz et al.
EUROPEAN UROLOGY (2014)
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy
Michael Rink et al.
BJU INTERNATIONAL (2013)
Impact of histological variants ononcological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy
Evanguelos Xylinas et al.
EUROPEAN JOURNAL OF CANCER (2013)
IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
Miao-Fen Chen et al.
PLOS ONE (2013)
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
Michael Rink et al.
EUROPEAN UROLOGY (2012)
Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma
Michael Rink et al.
EUROPEAN UROLOGY (2012)
Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer
Zhaowei Zhu et al.
MEDIATORS OF INFLAMMATION (2012)
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
Robert S. Svatek et al.
BJU INTERNATIONAL (2011)
The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
Robert S. Svatek et al.
CLINICAL CANCER RESEARCH (2010)
Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients
Giacomo Novara et al.
JOURNAL OF UROLOGY (2010)
Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2010)
Combination of Multiple Molecular Markers Can Improve Prognostication in Patients With Locally Advanced and Lymph Node Positive Bladder Cancer
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2010)
Statistical consideration for clinical biomarker research in bladder cancer
Shahrokh F. Shariat et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
Yair Lotan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
A Population Based Assessment of Perioperative Mortality After Cystectomy for Bladder Cancer
Hendrik Isbarn et al.
JOURNAL OF UROLOGY (2009)
Nomograms for bladder cancer
Shahrokh F. Shariat et al.
EUROPEAN UROLOGY (2008)
Challenges of cancer biomarker profiling
Karim Bensalah et al.
EUROPEAN UROLOGY (2007)
Association of pre- and postoperative plasma levels of transforming growth factor β1 and interleukin 6 and its soluble receptor with prostate cancer progression
SF Shariat et al.
CLINICAL CANCER RESEARCH (2004)
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy
SF Shariat et al.
JOURNAL OF UROLOGY (2004)
Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder
SF Shariat et al.
UROLOGY (2003)
Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer
B Andrews et al.
JOURNAL OF UROLOGY (2002)
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
SF Shariat et al.
UROLOGY (2001)
Share Paper
